The new report from the WHO Global Antimicrobial Resistance and Use Surveillance System is its most extensive, with estimates ...

Energy-based treatments and lasers for skin care have developed tremendously over the past decade, aided by the work of Eliot ...

To help patients navigate access challenges stemming from cuts under President Donald Trump's One Big Beautiful Bill, Brian Mulherin, MD, a hematologist-oncologist at the American Oncology Network, ...

Jenifer Soung, MD, fo Southern California Dermatology, discussed how glucagon-like peptide-1 receptor agonists aid in treating patients with psoriatic disease. Captions are auto-generated.

Lindsey Valenzuela, PharmD, explains how pharmacists can prevent drug interactions and improve coordination for women with arrhythmia and chronic disease.

Empathy, education, and shared decision-making are at the heart of improving respiratory care, according to a diverse panel ...

The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary ...

The AI tool offers precise alopecia assessment, improving accuracy and sensitivity over traditional methods like the SALT ...

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...

Cemiplimab (Libtayo; Regeneron Pharmaceuticals) has been approved as an adjuvant treatment for adult patients with cutaneous ...

Aumolertinib had comparable efficacy to osimertinib when treating epidermal growth factor receptor ( EGFR )-mutant non-small ...

Eliot F. Battle, MD, is a board-certified dermatologist, CEO and cofounder of New York Laser and Skin, and cochairman of the 2025 Skin of Color Update. Eliot F. Battle, MD, discusses the art of using ...